XTRA Bitcoin Inc (CBTC)

[MoneyForNuthin]

$CBTC XTRA Bitcoin, Inc. reverse merger with TCEL on June 25, 2019

8K filed on October 3, 2019:

https://www.otcmarkets.com/filing/html?id=13673632&guid=xgISUWznfTRImth

ITEM 1.01 ENTRY INTO A DEFINITIVE MATERIAL AGREEMENT

ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT

ITEM 8.01 OTHER EVENTS

Therapy Cells Inc. (the “Company”) will be filing its annual reports up through the as filed Form 15-12 filed on March 1, 2012. The Company will file its Annual Reports for fiscal year ended December 31, 2010 and December 31, 2011. Also, the OTC requires a companyfile the past two years of annual reports and current quarterly reports as a voluntary filer in an effort to be transparent to its shareholders and to be qualified to be a trading company on that trading site.

Therapy Cells Inc. has been unsuccessful in raising the required capital to pursue the FDA approval of the growing of Tendon and Articular cartilage for autotransplantation into humans. Their rights to the patents have expired and Company is no longer pursuing cell therapy.

Consistent with their business plan of investing in new and emerging technologies, Therapy Cells Inc has acquired all of the assets of XTRA Bitcoin Inc. through merger on June 25, 2019 and appointed a new Board and Officers. As part of this merger acquisition, Therapy Cells Inc. has changed its name to XTRA Bitcoin Inc. and committed to bringing its filings current. Paul Knudson has been appointed as a Director and serves as the CEO and CFO currently. As a result of this merger, Paul Knudson beneficially owns approximately 18.64% of the Company.

The Company’s principal place of business is 917 Bobwhite Street, Fruitland, Idaho 83619.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

THERAPY CELLS INC.

By: /s/ Paul Knudson
Paul Knudson
Chief Executive Officer